BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 22102565)

  • 1. Concise review: Embryonic stem cells versus induced pluripotent stem cells: the game is on.
    Puri MC; Nagy A
    Stem Cells; 2012 Jan; 30(1):10-4. PubMed ID: 22102565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of motor neurons differentiated from embryonic stem cells and induced pluripotent stem cells.
    López-González R; Velasco I
    Arch Med Res; 2012 Jan; 43(1):1-10. PubMed ID: 22293229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human stem cell research and regenerative medicine--present and future.
    Volarevic V; Ljujic B; Stojkovic P; Lukic A; Arsenijevic N; Stojkovic M
    Br Med Bull; 2011; 99():155-68. PubMed ID: 21669982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An overview of pluripotent stem cell lines].
    Kieffer E; Kuntz S; Viville S
    Med Sci (Paris); 2010 Oct; 26(10):848-54. PubMed ID: 20929676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lonely death dance of human pluripotent stem cells: ROCKing between metastable cell states.
    Ohgushi M; Sasai Y
    Trends Cell Biol; 2011 May; 21(5):274-82. PubMed ID: 21444207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human pluripotent stem cells for disease modelling and drug screening.
    Maury Y; Gauthier M; Peschanski M; Martinat C
    Bioessays; 2012 Jan; 34(1):61-71. PubMed ID: 22038777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regeneration.
    Yoshida Y; Yamanaka S
    Circulation; 2010 Jul; 122(1):80-7. PubMed ID: 20606130
    [No Abstract]   [Full Text] [Related]  

  • 9. Large chromatin domains in pluripotent and differentiated cells.
    Hu S; Cheng L; Wen B
    Acta Biochim Biophys Sin (Shanghai); 2012 Jan; 44(1):48-53. PubMed ID: 22194013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation.
    Jozefczuk J; Prigione A; Chavez L; Adjaye J
    Stem Cells Dev; 2011 Jul; 20(7):1259-75. PubMed ID: 21162674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Human embryonic stem cells: clinical potential and current challenges].
    Oliveri RS; Andersen CY
    Ugeskr Laeger; 2008 May; 170(21):1815-20. PubMed ID: 18492447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational potential of human embryonic and induced pluripotent stem cells for myocardial repair: insights from experimental models.
    Kong CW; Akar FG; Li RA
    Thromb Haemost; 2010 Jul; 104(1):30-8. PubMed ID: 20539906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between human embryonic stem cell lines.
    Allegrucci C; Young LE
    Hum Reprod Update; 2007; 13(2):103-20. PubMed ID: 16936306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pluripotent human stem cells for the treatment of retinal disease.
    Rowland TJ; Buchholz DE; Clegg DO
    J Cell Physiol; 2012 Feb; 227(2):457-66. PubMed ID: 21520078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cells: current challenges and future promise.
    Battey JF
    Dev Dyn; 2007 Dec; 236(12):3193-8. PubMed ID: 17584855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric analysis of human pluripotent stem cells.
    Ho MS; Fryga A; Laslett AL
    Methods Mol Biol; 2011; 767():221-30. PubMed ID: 21822878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The challenges and promises of blood engineered from human pluripotent stem cells.
    Dravid GG; Crooks GM
    Adv Drug Deliv Rev; 2011 Apr; 63(4-5):331-41. PubMed ID: 21232565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human embryonic stem cells: current technologies and emerging industrial applications.
    Améen C; Strehl R; Björquist P; Lindahl A; Hyllner J; Sartipy P
    Crit Rev Oncol Hematol; 2008 Jan; 65(1):54-80. PubMed ID: 17689256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells?
    Ronaghi M; Erceg S; Moreno-Manzano V; Stojkovic M
    Stem Cells; 2010 Jan; 28(1):93-9. PubMed ID: 19904738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models.
    Dambrot C; Passier R; Atsma D; Mummery CL
    Biochem J; 2011 Feb; 434(1):25-35. PubMed ID: 21269276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.